(Q42276725)

English

Low incidence rate of opportunistic and viral infections during imatinib treatment in chronic myeloid leukemia patients in early and late chronic phase

scientific article published on 16 May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Low incidence rate of opportunistic and viral infections during imatinib treatment in chronic myeloid leukemia patients in early and late chronic phase (English)

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

chronic myeloid leukemia

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Giuliana Alimena

10

object named as

Giuliana Alimena

1 reference

Europe PubMed Central

19 October 2017

PMC publication ID

Massimo Breccia

1

object named as

Massimo Breccia

1 reference

Europe PubMed Central

19 October 2017

PMC publication ID

Roberto Latagliata

3

object named as

Roberto Latagliata

1 reference

Europe PubMed Central

19 October 2017

PMC publication ID

author name string

Corrado Girmenia

2

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Giuseppina Loglisci

4

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Michelina Santopietro

5

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Vincenzo Federico

6

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Luigi Petrucci

7

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Alessandra Serrao

8

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Adriano Salaroli

9

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

publication date

16 May 2011

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Mediterranean journal of hematology and infectious diseases

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

3

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

1

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

e2011021

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

First-Line management of CML: a state of the art review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113277

26 October 2017

Development and dynamics of robust T-cell responses to CML under imatinib treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113277

26 October 2017

Occurrences of opportunistic infections in chronic myelogenous leukemia patients treated with imatinib mesylate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113277

17 August 2018

Tuberculosis complicating imatinib treatment for chronic myeloid leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113277

17 August 2018

Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113277

17 August 2018

Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113277

17 August 2018

Pneumonia caused by Candida krusei and Candida glabrata in a patient with chronic myeloid leukemia receiving imatinib mesylate treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113277

17 August 2018

Imatinib mesylate inhibits antigen-specific memory CD8 T cell responses in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113277

17 August 2018

Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113277

17 August 2018

Listeria monocytogenes meningitis following imatinib mesylate-induced monocytopenia in a patient with chronic myeloid leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113277

17 August 2018

Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113277

17 August 2018

Pulmonary nocardiosis in a patient with CML relapse undergoing imatinib therapy after bone marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113277

17 August 2018

EBV-positive cutaneous B-cell lymphoproliferative disease after imatinib mesylate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113277

17 August 2018

Chronic myeloid leukemia patients resistant to or intolerant of interferon alpha and subsequently treated with imatinib show reduced immunoglobulin levels and hypogammaglobulinemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113277

17 August 2018

Development of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113277

17 August 2018

Identifiers

10.4084/MJHID.2011.021

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42276725&oldid=1940928793"